Park Medi World logo

Park Medi World

PARKHOSPS NSE

Key Fundamentals

MicrocapHospitalsHealthcare Services
Market Cap
₹12,027 Cr
Volatility
Moderate
P/E Ratio
42.13
EBITDA
₹476 Cr
Return on Equity
13%
Debt to Equity
0.18
Book Value
₹46.54
52W High
₹305
52W Low
₹138.1

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

1
  • Though the company is reporting repeated profits, it is not paying out dividend

Growth Rate

Revenue Growth
19.99% higher than 3Y
Net Income Growth
27.02% higher than 3Y
Cash Flow Change
52.8% higher than 3Y
ROE
-32.5% lower than 3Y
ROCE
-17.35% lower than 3Y
EBITDA Margin (Avg.)
-1.66% lower than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 38d ago
AI opinion · based on fundamentals
Risk medium

Park Medi World Ltd is a mid-cap healthcare services company with a market cap of approximately ₹12,396 Cr, trading at a PE of 41.5x. The company delivered FY26 revenue of ₹1,679 Cr (21% YoY growth) and net profit of ₹274 Cr (28% YoY growth), with a 5-year ROE average of 24% and operating margins around 26%. It pays no dividend despite consistent profitability.

Bull Case 7
  • Strong revenue growth of 21% TTM (FY26 revenue ₹1,679 Cr vs ₹1,394 Cr in FY25), accelerating from the 3-year sales CAGR of 10%
  • Net profit grew 28% YoY in FY26 (₹274 Cr vs ₹213 Cr), with TTM profit growth of 25% outpacing sales growth, indicating operating leverage
  • Healthy 5-year average ROE of 24% demonstrates consistent capital efficiency well above cost of equity for the sector
  • Company has reduced debt, with interest costs declining from ₹70 Cr in FY24 to ₹59 Cr in FY26, improving financial flexibility
  • Operating profit margin stable at ~26% in FY26 (₹444 Cr on ₹1,679 Cr revenue), showing pricing power in a competitive healthcare market
  • Q4 FY26 revenue of ₹460 Cr showed 30% YoY growth, suggesting further momentum into FY27
  • 5-year compounded profit growth of 11% with acceleration to 25% TTM signals improving earnings trajectory
Bear Case 8
  • PE of 41.5x is elevated for a healthcare services company with a 3-year profit CAGR of only 5%, implying the stock prices in significant future growth
  • Zero dividend yield despite repeated profitability — no capital return to shareholders even as net profit reached ₹274 Cr in FY26
  • Price-to-book of 6.12x is rich, leaving limited margin of safety if growth decelerates
  • 3-year compounded profit CAGR of only 5% (vs 25% TTM) indicates earnings have been volatile, with FY24 net profit dipping to ₹152 Cr from ₹228 Cr in FY23
  • Tax rate fluctuation (from 30% in FY24 to 23% in FY26) has flattered recent profit growth; normalization could compress earnings
  • OPM declined from 30.7% in FY23 to 26% in FY26, a ~470 bps contraction suggesting rising cost pressures despite topline growth
  • ROE has moderated from 24% (5-year average) to 17% in the last year, pointing to diminishing returns on incremental capital deployed
  • Lack of available 52-week high/low data and limited stock CAGR history suggest relatively thin trading history and potential liquidity risk at ₹12,396 Cr market cap

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 33d ago
Positives 4
  • Q1FY27 profit up 35% YoY Aug 5

    Net profit rose 35% YoY to ₹886 million for Q1FY27, driven by 19% revenue growth.

  • Dual acquisitions boost scale Aug 3

    Acquired Mehar Hospital for ₹1,070 million and V3 Healthcare for ₹1,770 million, adding capacity and geographic reach.

  • 330-bed Rudrapur hospital launched Aug 2

    Launched The Medicity Hospital in Rudrapur (330 beds), marking entry into Uttarakhand and expanding North India footprint to six states.

  • Aggressive bed expansion plan Aug 3

    MD targets 4,740 beds by end of FY27 and 5,740 beds by March 2028, adding 1,000 beds in FY28.

Neutral 3
  • IPO proceeds reallocation sought Aug 4

    Postal ballot seeks shareholder approval to redirect ₹648.32 million in unutilised IPO proceeds toward acquiring The Medicity Hospital, Rudrapur. E-voting runs Aug 05–Sep 03, 2026.

  • Investor conferences in August Aug 5

    Management to participate in three investor conferences in Mumbai on August 12, 13, and 25, 2026; no UPSI to be discussed.

  • Q1FY27 earnings call completed Aug 4

    Earnings conference call held on August 4, 2026, discussing unaudited standalone and consolidated Q1FY27 results.

TL;DR: Park Medi World is delivering strong earnings growth (35% YoY profit increase) while simultaneously scaling through acquisitions and new hospital launches. The expansion strategy is well-structured with clear bed capacity targets through FY28. No material headwinds are visible in recent news flow. The trend is firmly positive, though execution risk on rapid expansion and integration of acquired assets bears monitoring.

Quarterly Results

Particulars Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
348
354
399
410
410
460
476
Expenses
265
265
294
297
311
333
350
Operating Profit
83
88
105
113
99
127
126
OPM %
24%
25%
26%
27%
24%
28%
26%
Other Income
15
9
7
8
9
8
8
Interest
16
16
15
15
15
14
10
Depreciation
15
16
15
15
15
18
19
PBT
67
66
82
91
78
103
105
Tax %
32%
20%
20%
14%
32%
26%
16%
Net Profit
46
52
66
79
53
77
89
EPS in Rs
2.97
1.17
1.51
1.91
1.17
1.64
1.91
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
766
1,084
1,255
1,231
1,394
1,679
1,756
Expenses
457
740
863
919
1,020
1,233
1,291
Operating Profit
309
345
391
312
374
446
466
OPM %
40%
32%
31%
25%
27%
27%
27%
Other Income
3
9
15
29
30
32
32
Interest
24
40
51
72
62
61
53
Depreciation
24
35
41
51
57
62
67
PBT
265
278
315
218
286
355
378
Tax %
26%
28%
28%
30%
25%
23%
—
Net Profit
187
199
228
152
215
274
297
EPS in Rs
80.54
11.76
14.29
9.98
5.25
5.98
6.63
Div. Payout %
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
19
77
77
77
77
86
Reserves
256
380
610
806
975
1,936
Borrowings
292
517
576
687
682
364
Other Liabilities
249
319
331
343
393
411
Total Liabilities
816
1,293
1,593
1,912
2,127
2,797
Fixed Assets
365
458
536
837
890
1,309
CWIP
7
29
5
32
37
123
Investments
0
0
0
0
0
0
Other Assets
443
806
1,052
1,043
1,199
1,365
Total Assets
816
1,293
1,593
1,912
2,127
2,797
Figures in ₹ Crores

Cash Flow

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
223
155
199
367
215
329
Investing
-233
-248
-234
-76
-100
-316
Financing
49
163
1
-130
-89
121
Net Cash Flow
39
70
-34
161
26
134
Free Cash Flow
86
64
106
299
70
209
CFO/OP
96
72
76
150
80
96
Figures in ₹ Crores

Ratios

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
151
151
168
151
161
129
Inventory Days
47
14
3
3
3
4
Days Payable
121
101
110
133
176
134
Cash Conversion Cycle
77
64
61
21
-12
-2
Working Capital Days
40
60
40
21
30
28
ROCE %
—
38%
31%
20%
20%
19%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Park Medi World insights

43 extracted metrics + investor summaries across FY21–FY27.

Log in — free

Shareholding Pattern

FIIs0.82%Promot.82.89%Others2.79%Public4.54%DIIs8.95%As ofJun 2026

Documents

Frequently Asked Questions about Park Medi World

What does Park Medi World Ltd do?
Park Medi World engaged in the business of, inter alia, establishing, maintaining and running hospitals, nursing homes, clinics, dispensaries, maternity homes, child welfare, family planning etc.(Source : 202503 Annual Report Page No:320)
Where is Park Medi World Ltd (PARKHOSPS) listed?
Park Medi World Ltd trades as PARKHOSPS on the NSE and under code 544645 on the BSE.
Which sector does Park Medi World Ltd belong to?
Park Medi World Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of Park Medi World Ltd?
Park Medi World Ltd has a market capitalisation of ₹12,027 Cr, which places it in the Mid Cap band.
What is the PE ratio of Park Medi World Ltd?
Park Medi World Ltd trades at a PE ratio of 42.13, against a book value of ₹46.54 per share.
What is the 52-week high and low of Park Medi World Ltd?
Over the last 52 weeks Park Medi World Ltd has traded between ₹138.1 and ₹305.
What is the Return on Equity (ROE) of Park Medi World Ltd?
Park Medi World Ltd reported a return on equity of 13.00%. Its debt-to-equity ratio is 0.18.

Company Information

Park Medi World engaged in the business of, inter alia, establishing, maintaining and running hospitals, nursing homes, clinics, dispensaries, maternity homes, child welfare, family planning etc.(Source : 202503 Annual Report Page No:320)

Website parkhospital.in
Listed 2025-12-17
Face Value ₹ 2
Issued Size 43,19,30,864

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PARKHOSPS.md for Park Medi World Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List